Voice restoration without surgery
Konrad Zieliński lost his voice to cancer while studying at the University of Warsaw. After years of relying on flat, robotic speaking devices, he built a noninvasive alternative that lets people who have had their larynxes removed speak with emotion, laugh, shout, and sing. His startup, Uhura Bionics, will showcase the technology at TechCrunch Disrupt 2026 as one of the Startup Battlefield 200 companies.
People with Zieliński's condition typically choose between handheld speaking devices with limited emotional range or surgically implanted voice prostheses that require ongoing maintenance. Zieliński, who completed a PhD on bionic systems for laryngectomees, wanted a third option: a wearable device requiring no surgery.
Uhura Bionics now offers two models. The basic version costs $500, while the high-end device, called Whitney after Whitney Houston, sells for $1,500. Zieliński said he hopes laryngectomees will use Whitney the way people with poor eyesight use glasses.
How the device sounds
"I'm satisfied with what I've built because you added the emotional layer," Zieliński said in a voice that carries intonation, though with a slight electronic undertone. The emotional range is the core selling point over older devices that produce flat, monotone speech.
The next development phase includes higher-pitched voice options for women and personalization features so users don't all sound alike. Zieliński will demonstrate Whitney's capabilities at TechCrunch Disrupt and at SF Tech Week in October, where he plans to sing onstage with the device.
Regulatory path and market
Uhura currently sells its products as wellness devices, meaning users pay out of pocket. The startup is seeking Class I medical device classification in Europe first, then the U.S. That status would allow partial reimbursement through health insurance.
Zieliński estimates the market for devices serving laryngectomees at about $2 billion. That figure could grow if Uhura expands to serve people with other speech disorders. Competitors include Atos Medical and startups like Laronix.
Why this matters for healthcare professionals
For clinicians who work with laryngectomy patients, a noninvasive device with emotional range addresses a persistent gap: surgical prostheses carry maintenance and complication risks, while traditional electrolarynxes sound robotic. If Uhura secures Class I classification, reimbursement pathways could make the technology accessible to patients who currently decline or cannot afford surgical options. The $500 entry price point also matters for outpatient settings where cost sensitivity shapes device recommendations.
Your membership also unlocks:
